<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Immun</journal-id><journal-id journal-id-type="pmc-domain-id">87</journal-id><journal-id journal-id-type="pmc-domain">iai</journal-id><journal-id journal-id-type="publisher-id">iai</journal-id><journal-title-group><journal-title>Infection and Immunity</journal-title></journal-title-group><issn pub-type="ppub">0019-9567</issn><issn pub-type="epub">1098-5522</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC219583</article-id><article-id pub-id-type="pmcid-ver">PMC219583.1</article-id><article-id pub-id-type="pmcaid">219583</article-id><article-id pub-id-type="pmcaiid">219583</article-id><article-id pub-id-type="pmid">14573645</article-id><article-id pub-id-type="doi">10.1128/IAI.71.11.6264-6269.2003</article-id><article-id pub-id-type="publisher-id">0658</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Microbial Immunity and Vaccines</subject></subj-group></article-categories><title-group><article-title>Evaluation of <italic>Brucella abortus</italic> Phosphoglucomutase (<italic>pgm</italic>) Mutant as a New Live Rough-Phenotype Vaccine </article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ugalde</surname><given-names initials="JE">Juan Esteban</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Comerci</surname><given-names initials="DJ">Diego Jos&#233;</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leguizam&#243;n</surname><given-names initials="MS">M. Susana</given-names></name><xref ref-type="aff" rid="aff1">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ugalde</surname><given-names initials="RA">Rodolfo Augusto</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">Instituto de Investigaciones Biotecnol&#243;gicas, Universidad Nacional de General San Mart&#237;n, Consejo Nacional de Investigaciones Cient&#237;ficas,<label>1</label> Grupo Pecuario, Centro At&#243;mico Ezeiza, Comisi&#243;n Nacional de Energ&#237;a At&#243;mica,<label>2</label> Departamento de Microbiolog&#237;a, Parasitolog&#237;a e Inmunolog&#237;a, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina<label>3</label></aff><author-notes><fn id="cor1"><label>*</label><p>Corresponding author. Mailing address: IIB-UNSAM, Av General Paz entre Constituyentes y Albarellos, PO Box 30 (1650) San Mart&#237;n, Provincia de Buenos Aires, Argentina. Phone: 54-11-4580-7255/57. Fax: 54-11-4752-9639. E-mail: <email>rugalde@iib.unsam.edu.ar</email>.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2003</year></pub-date><volume>71</volume><issue>11</issue><issue-id pub-id-type="pmc-issue-id">6793</issue-id><fpage>6264</fpage><lpage>6269</lpage><history><date date-type="received"><day>14</day><month>5</month><year>2003</year></date><date date-type="rev-recd"><day>27</day><month>6</month><year>2003</year></date><date date-type="accepted"><day>13</day><month>7</month><year>2003</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2003</year></date></event><event event-type="pmc-live"><date><day>12</day><month>12</month><year>2003</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-10 12:25:27.350"><day>10</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2003, American Society for Microbiology</copyright-statement><copyright-year>2003</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="0658.pdf"/><abstract><p><italic>Brucella abortus</italic> S19 is the vaccine most frequently used against bovine brucellosis. Although it induces good protection levels, it cannot be administered to pregnant cattle, revaccination is not advised due to interference in the discrimination between infected and vaccinated animals during immune-screening procedures, and the vaccine is virulent for humans. Due to these reasons, there is a continuous search for new bovine vaccine candidates that may confer protection levels comparable to those conferred by S19 but without its disadvantages. A previous study characterized the phenotype associated with the phosphoglucomutase (<italic>pgm</italic>) gene disruption in <italic>Brucella abortus</italic> S2308, as well as the possible role for the smooth lipopolysaccharide (LPS) in virulence and intracellular multiplication in HeLa cells (J. E. Ugalde, C. Czibener, M. F. Feldman, and R. A. Ugalde, Infect. Immun. <bold>68:</bold>5716-5723, 2000). In this report, we analyze the protection, proliferative response, and cytokine production induced in BALB/c mice by a &#916;<italic>pgm</italic> deletion strain. We show that this strain synthesizes O antigen with a size of approximately 45 kDa but is rough. This is due to the fact that the &#916;<italic>pgm</italic> strain is unable to assemble the O side chain in the complete LPS. Vaccination with the &#916;<italic>pgm</italic> strain induced protection levels comparable to those induced by S19 and generated a proliferative splenocyte response and a cytokine profile typical of a Th1 response. On the other hand, we were unable to detect a specific anti-O-antigen antibody response by using the fluorescence polarization assay. In view of these results, the possibility that the &#916;<italic>pgm</italic> mutant could be used as a vaccination strain is discussed.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn><p><italic>Editor:</italic> W. A. Petri, Jr.</p></fn></fn-group></notes></front></article></pmc-articleset>